From the Executive Director's Desk

Nominating Committee Finalizes Board Slate

By: Margaret M. Timony
DCAT Executive Director

Since May, DCAT’s Nominating Committee has been meeting and preparing a slate of well-qualified candidates to lead the organization in the upcoming years. During the course of the committee’s process this year, the organization’s leadership announced its decision to no longer support programs and events for the Nutrition and Health segment. Therefore, the Nominating Committee did not seek a candidate to represent that segment on the Executive Committee. After some analysis, the leadership and the Nominating Committee decided that a representative of members involved in contract formulation, fill, finish and contract packaging should replace the Nutrition and Health Segment on the Executive Committee.

As always, this year we had a tremendous response to our Call For Nominations for the Board of Directors. DCAT has no shortage of industry leaders and willing volunteers who would like to serve on the board. However, there are a limited amount of positions to fill each year, so unfortunately not everyone can be slated by the Nominating Committee for election. I want to thank each and every person who sent in applications for themselves or for colleagues. Your interest and support is greatly appreciated.

The Nominating Committee’s proposed slate is scheduled to be sent to each members company’s Designated Contact in September. Per our organizational bylaws, we give our member companies the right to say whether or not they support the committee’s decision.

You can get involved too! Join a committee, participate in programs or just contact us to make suggestions. Your ideas keep the organization viable and successful.

Here is the committee’s slate of candidates for 2010:

Officers of the Executive Committee of the Board of Directors (1 Year Term):
President:
Bob Kanuga, Ex. Director, External Manufacturing Operations, Merck & Co., Inc.
Sr. Vice President:
Joan Connolly, Associate Vice President, Clinical Supplies and Logistics, ImClone Systems Inc.
Finance Officer:
Tyson Popp, Vice President, Research & Development, West Pharmaceutical Services, Inc.
Vice President:
Lyra Myers, Senior Procurement Manager, cGMP Procurement, Genentech, Inc.

Segment Vice Presidents of the Executive Committee of the Board of Directors
(1 Year Term):
Biotechnology Industry Segment Vice President:
Dave Cady, Director, Global Strategic Sourcing, Amgen Inc.
Chemical Industry Segment Vice President:
Donald LaFerle, President, Sales and Marketing, IRIX Pharmaceuticals, Inc.
Contract Formulation/Fill/Finish & Contract Packaging Industry Segment Vice President:
Pam Tyler, Purchasing Manager, DPT Labs, Ltd.
Pharmaceutical Industry Segment Vice President:
Ron Perry, Sr. Director, Worldwide Procurement, Pfizer Inc.
Pharmaceutical Services Industry Segment Vice President:
David McCleary, President, Custopharm, Inc. 

Board of Directors (3 Year Term):
Ellen Gambichler, Director of Purchasing, Nycomed US
Michael Kopp, Vice President, North American Injectables, Mylan Pharmaceuticals
Michael Rosenfelder, Director of Business Development, Merck & Co., Inc.
Joe Sutton, Director, Manufacturing Procurement, Eli Lilly and Company
Ruben Valdez, Global Sourcing Lead, Hospira, Inc.
Mike Velez, Sourcing Director, Merck & Co., Inc.

The staff and I look forward to working with our new leaders in the upcoming year!